Enhancing theranostic potential of anti-mesothelin sdAb through site-specific labeling at a unique conserved lysine by molecular engineering
Émilien N’Guessan(Inserm), Alexis Broisat(Inserm)
Cited by 2
Related Papers
Early reduced dopaminergic tone mediated by D3 receptor and dopamine transporter in absence epileptogenesis
|Epilepsia|2019|11
Side by side comparison of NOTA and DOTA for conjugation efficiency, gallium-68 labeling, and in vivo biodistribution of anti-mesothelin sdAb A1-His
|EJNMMI Radiopharmacy and Chemistry|2025|6